Archer Daniels-Midland (ADM) reported a Q1 earnings per share of $0.71, exceeding expectations of $0.66, highlighting effective cost management strategies. Although revenues fell to $20.49 billion, 2.93% below consensus estimates, shares rose over 5%, signaling investor confidence. This strong performance occurs against a backdrop of a widening U.S. Trade Balance deficit, which reached $60.3 billion in March, raising concerns over broader economic stability.
“Archer Daniels-Midland · outperformed expectations on · Q1 bottom line · +0.71 per share”
“Archer Daniels-Midland · surpassed anticipated earnings of · $0.66 · null”
“Archer Daniels-Midland · reported revenues of · $20.49 billion · null”
“Archer Daniels-Midland · revenues came in · -2.93% lower than consensus · null”
“U.S. Trade Balance · deficit · March · -$60.3 billion”
“U.S. Trade Balance · previous month's deficit · February · -$57.8 billion”
“U.S. Trade Balance · import growth · March · +2.3%”
“U.S. Trade Balance · export growth · March · +2.0%”
“Pfizer PFE · earnings per share · Q1 · +0.75”
“Pfizer PFE · earnings expectations beat · Q1 · +4 cents”
“Pfizer PFE · revenue · Q1 · $14.45 billion”
“Pfizer PFE · revenue growth · Q1 · +4.56%”
.svg&width=160)
.svg&width=160)